Oct 25 (Reuters) - Apple (AAPL.O), opens new tab convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's (MASI.O), opens new tab smartwatches infringe two ...

With its AI offering expected to be a huge driver of sales, 24/7 Wall St. projects significant upside for Apple stock through ...

In late 2023, Apple received a small blow to its lucrative Christmas sales period thanks to the medical device manufacturer ...

Apple is appealing the ITC's Apple Watch injunction, but it has been able to continue selling the Apple Watch by disabling the blood oxygen sensor that allegedly infringes on Masimo's technology.

Back in 2013, Apple reportedly contacted Masimo to discuss a potential collaboration between the two companies. Instead, claims Masimo, Apple used the meetings to identify staff it wanted to poach.

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo’s W1 ...

Apple attorney John Desmarais told Bloomberg Law, “We’re not here for the money… we want [Masimo] to stop copying our design.” Meanwhile, Masimo is counting the whole lawsuit as a win.

What Apple, which is worth $3.5 trillion, wanted was an injunction on the sales of Masimo's current smartwatch models. However, the jury determined that those newer models don't violate Apple's ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...

Apple, as you might imagine, seeks to paint things differently. “We thank the jury for their careful consideration in this case, finding Masimo willfully infringed Apple’s patented designs ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo’s W1 ...